Future studies screening BRCA1/BRCA2 mutations in an unselected BC population prospectively should be conducted to further examine differences in clinicopathological characteristics in BRCA1/BRCA2-positive and BRCA1/BRCA2-negative patients in the general BC population. The gene discussed is BRCA2; the disease is breast cancer.